Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine versus dexmedetomidine versus placebo for pediatric adenotonsillectomy premedication
IRCT20100518003954N9Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Adenotonsillar hypertrophy (ATH) comparing Intranasal ketamine, Intranasal dexmedetomidine and Intranasal normal saline placebo (3 arms). Primary endpoint: Pre-anesthesia relaxation. Started Aug 2018; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Adenotonsillar hypertrophy (ATH)
Beyond the preview
Go deeper on IRCT20100518003954N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100518003954N9.